Post Profile






Chemotherapy drives treatment resistance in bladder cancer

(Weill Cornell Medicine) Chemotherapy is indicated as the first line of treatment for advanced bladder cancer. New research by Weill Cornell Medicine and University of Trento scientists shows that while chemotherapy kills the most common type of bladder cancer, urothelial cancer, chemotherapy also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant.
read more

share

Related Posts


Targeting Newly Discovered Pathway Sensitizes Tumors to Radiation and Chemotherapy

Health : Newswise Medical News

In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identi...

What Drives Advanced Prostate Cancer? New Study Describes Genomic Landscape

Health : Newswise Medical News

In a major advance in precision medicine, an international collaboration of researchers found 90 percent of castration resistant metastatic prostate cancers harbored some kind of genetic anomaly that could drive treatment choices.

MD Anderson Study Shows Why Some Brain Cancers Resist Treatment

Health : Newswise Medical News

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Study Shows More Hospital Deaths and Invasive Care for Dying Cancer Patients Who Receive Chemotherapy

Health : Newswise Medical News

A study by researchers at Dana-Farber Cancer Institute and Weill Cornell Medical College shows terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more l...

Treatment shrinks bladder cancer tumors in patients that can't tolerate chemotherapy

Health : EurekAlert: Health

(NYU Langone Medical Center / New York University School of Medicine) A treatment harnesses the immune system to shrink tumors in bladder cancer patients that cannot take the most effective chemotherapy.

Comments


Copyright © 2016 Regator, LLC